UCL Faculty of Medical Sciences

Congratulations Team REWIRE-CAN!!

UCL-led international research team wins $25m Cancer Grand Challenges funding Team REWIRE-CAN, led by Professor Bart Vanhaesebroeck of the UCL Cancer Institute, will receive up to $25m over approximately five years to take on the rewiring cancer cells challenge.

Congratulations to Prof Bart Vanhaesebroeck, Prof @christophertape.bsky.social & Team REWIRE-CAN on securing $25m in @cancergrand.bsky.social funding to take on the challenge of rewiring cancer cells.

#CancerGrandChallenges @uclmedsci.bsky.social

www.ucl.ac.uk/news/2026/ma...

Today, UCL turns 200. 🎉 For two centuries, our community has opened doors, challenged convention and pushed the boundaries of knowledge across every discipline. Thank you to everyone who’s been part of the UCL story, here’s to the next century. ✨

#UCL200 #LoveUCL

UCL celebrates 200 years: A landmark year begins Today, UCL marks 200 years since its foundation. Based in the heart of London, UCL is rooted in curiosity, tolerance and academic excellence. Throughout the year we will celebrate two centuries of lea...

💜 Today, @ucl.ac.uk marks 200 years since its foundation.
Throughout 2026, we will celebrate two centuries of learning and innovation and share those achievements with our global community.

➡️Discover our exciting #UCL200 programme of events and learn how you can get involved.

French Ambassador visit to @ucl.ac.uk and UCLH: a great moment to highlight UCL’s strengths in health, research and innovation — and the Franco–British collaboration behind it, spanning @uclmedsci.bsky.social and Computer Science.

#UCLEurope

@profgeraintrees.bsky.social

Text reads: UCL ranked #3 in Europe. QS World University Rankings Europe 2026.

UCL has risen two places to be named third best university in Europe according to the QS World University Rankings: Europe 2026. 🥉 This achievement reflects our extensive European partnerships across research, education, and innovation.

Read more: https://bit.ly/3LHcuxz

Register now! The @ucl.ac.uk Advanced Therapies Symposium returns on 22 April 2026. This event brings together 250+ researchers, clinicians, funders & industry to explore breakthroughs from lab to market. More info: bit.ly/4j8kjIL

@uclenterprise.bsky.social @uclb.bsky.social

People on weight loss drugs without support may be vulnerable to nutritional deficiencies People prescribed the new generation of weight loss drugs may not receive sufficient nutritional guidance to support safe and sustainable weight loss, leaving them vulnerable to nutritional deficienci...

People prescribed the new generation of weight loss drugs may not get the nutritional guidance they need for safe and sustainable weight loss, leaving them vulnerable to nutritional deficiencies and muscle loss, say experts led by Dr Adrian Brown @arrdept-ucldom.bsky.social @uclmedsci.bsky.social

UCL researcher awarded medal for improving prostate cancer care Dr Veeru Kasivisvanathan (UCL Division of Surgery & Interventional Science) has been awarded the prestigious Society of Apothecaries’ 2026 William Farr Medal in recognition of his research advancing p...

Congratulations to Dr Veeru Kasivisvanathan @uclmedsci.bsky.social who has been awarded the prestigious Society of Apothecaries’ 2026 William Farr Medal in recognition of his research advancing prostate cancer care globally www.ucl.ac.uk/news/2026/ja...

World-first project shows great promise to treat low eye pressure A new study demonstrates the effectiveness of a widely-used eye injection to manage the previously untreatable rare condition, hypotony, in a project by clinical researchers at UCL and Moorfields Eye ...

A new study demonstrates the effectiveness of a widely-used eye injection to manage the previously untreatable rare condition, hypotony (abnormally low eye pressure), in a project by researchers at @ucleye.bsky.social, @moorfields.bsky.social, @uclengineering.bsky.social and @uclmedsci.bsky.social

HBV/HIV co-infection linked to stronger immune responses than HBV alone Contrary to long-held assumptions, new UCL-led research shows people with both hepatitis B (HBV) and HIV can maintain strong immune responses to hepatitis B when it is treated with antivirals.

New research from the UCL Institute of Immunity and Transplantation has shown that people with both hepatitis B and HIV can maintain strong immune responses to hepatitis B when it is treated with antivirals, challenging assumptions and opening doors for new treatments 🔬
www.ucl.ac.uk/medical-scie...

TINs Industry Club 2026 Funding Call is OPEN!
Apply by 16 Jan 2026 for short, high-impact projects (1–3 months, up to £20K) co-delivered by @ucl.ac.uk PIs & industry partners. Focus: therapeutic innovations with clear commercialisation pathways.
Details: bit.ly/49ZeNWs

UCL’s festive gift guide is live, showcasing unique products from UCL entrepreneurs, all of which have received support from UCL Innovation & Enterprise. 🎄🎁

Discover gifts from bespoke cakes to eco-friendly coffee cups and jewellery made from recycled electronics.

Check it out: bit.ly/48dom2R

UCL team uncovers protein structure behind antitrypsin deficiency Research led by Professor David Lomas & Dr James Irving has mapped the structure of abnormal protein chains that cause liver and lung disease in people with antitrypsin deficiency.

A research team including Prof David Lomas & Dr James Irving has mapped the structure of abnormal protein chains that cause liver and lung disease in people with antitrypsin deficiency, inspiring hope for new treatment 🔬

www.ucl.ac.uk/medical-scie...

Treating gum disease could reduce risk of heart attacks and strokes Intensive treatment of severe gum disease can help prevent arteries from becoming clogged, supporting heart health and reducing the long-term risk of developing cardiovascular diseases such as coronar...

Intensive treatment of severe gum disease can prevent clogged arteries, reducing the risk of cardiovascular diseases such as heart attacks, according to a new clinical trial by Dr Marco Orlandi, Prof Francesco D'Aiuto and Prof John Deanfield @uclmedsci.bsky.social @uclpophealthsci.bsky.social

Life and Medical Sciences Postgraduate Open Evening Discover our Master’s degrees in Brain Sciences, Life Sciences, Medical Sciences, Population Health Sciences and Medical Engineering.

Thinking about a Master’s in life or medical sciences?

Join us at our Postgraduate Open Evening on 19 November to meet academics and explore your options.

🕔 Wednesday 19 November, 16:30–19:30
📍 UCL Institute of Education (IOE), Bloomsbury Campus
🔗 Book your place:

Launch of the Grand Challenge of Transformative Technology Impact Report UCL Grand Challenges has launched the Grand Challenge of Transformative Technology Impact Report, celebrating almost a decade of pioneering research and collaboration exploring how innovation and tech...

🚀 Just launched! UCL's Grand Challenge of Transformative Technology Impact Report

Celebrating the work of researchers, innovators & partners from UCL and beyond, the report highlights how innovation can improve lives and benefit humanity.

🔗 https://bit.ly/4niclx3

Thinking about postgraduate study at UCL?

Join our online sessions next week to hear directly from our Admissions and Student Funding teams, get practical advice, and ask your questions.

🔗 Register here: https://direc.to/nrPW

#UCLGraduateOpenEvents

🧠 Today is #WorldMentalHealthDay
At UCL Grand Challenges, we’re spotlighting research that’s driving change—from early intervention to wellbeing in schools, hospitals, and workplaces.
Explore how we’re shaping policy and practice: https://bit.ly/46zVlfm
#MentalHealth #UCL

New drug combination offers hope for men with advanced prostate cancer A new drug combination could significantly delay the progression of a life-threatening form of prostate cancer in men with specific genetic mutations, finds a major international trial led by UCL rese...

A new drug combination could significantly delay the progression of a life-threatening form of prostate cancer in men with specific genetic mutations, finds a major international trial led by Prof Gerhardt Attard @uclmedsci.bsky.social
www.ucl.ac.uk/news/2025/oc...

New Science Lead appointed to Institute for Liver & Digestive Health Dimitrios Anastasiou has been appointed Professor of Metabolic Systems and Science Lead at UCL’s Institute for Liver & Digestive Health (ILDH).

A warm welcome to Dimitrios Anastasiou, who has joined the Division of Medicine as Professor of Metabolic Systems and the new Science Lead at the Institute for Liver & Digestive Health.

His work in metabolism, cancer and liver disease will be a tremendous asset to UCL 🔬

@uclnews.bsky.social

PhD Studentships For students embarking on their research career Applications for 2026 PhD studentships are open! Applications are open! The PhD programme PhD students, funded by the CoL Centre, will follow th...

Are you interested in doing a #PhD in #cancerresearch? 🧪🧑‍🔬👨🏽‍🔬👩🏿‍🔬🧫🦠🔬 Do you want to develop new #biotherapeutics? Applications for our fully funded 4-year PhD programme starting in Autumn 2026 are open now!
bit.ly/4gS9vND
#uclcancer #QMBCI #KCLcancer_pharm #KCL #TheCrick

A global clinical trial for a new Huntington’s disease treatment has posted positive results today, announced by trial sponsor uniQure and UCL scientists Prof Sarah Tabrizi and @profwild.bsky.social @uclqsion.bsky.social @uclbrainscience.bsky.social. Watch on BBC News at One 📺

Inequalities in Focus: UCL Grand Challenges launches podcast mini-series on Inclusive & Just Futures As part of our Disruptive Voices series, this mini-series invites you to engage in thought-provoking conversations with UCL researchers and interdisciplinary experts who are tackling some of society’s...

🎙️ New Podcast Mini-Series: Inequalities in Focus
As part of our Disruptive Voices series, this mini-series invites you to engage in thought-provoking conversations with UCL researchers & interdisciplinary experts who are tackling some of society’s most pressing inequalities.
🎧👇https://bit.ly/42x2Rqv

At UCL, AI is revolutionising dementia research; from faster Alzheimer’s diagnosis to tracking progression and developing new treatments.
This #WorldAlzheimersMonth, explore how our neuroscience experts are improving lives: www.youtube.com/watch?v=QKQv...

Why Merck and AstraZeneca may regret turning their back on Britain The pair may have gone cold on the UK but start-ups and university spinouts here are using AI to revolutionise drug discovery

Could these companies be turning their backs at precisely the wrong moment?, asks @profgeraintrees.bsky.social after US firm Merck put the brakes on a £1 billion London research centre & AstraZeneca said it would pause a £200m investment to expand its research and development arm in Cambridge

Molecular test personalises prostate cancer treatment Testing the molecular profile of tumours identifies which patients with advanced prostate cancer are more likely to benefit from chemotherapy and live longer, sparing patients less likely to benefit f...

A new test can identify which prostate cancer patients are more likely to benefit from chemotherapy and live longer, sparing patients less likely to benefit from unpleasant side effects, shows a new study led by Prof Gert Attard & Dr Emily Grist @uclmedsci.bsky.social
www.ucl.ac.uk/news/2025/au...

Carmen Rodriguez of @uclmedsci.bsky.social was highly commended in our 2025 Image Competition. Her image shows the interaction between osteosarcoma (bone cancer) and osteoclasts, which can be corrupted to help the tumour spread. Scientists are exploring how to support the immune system to respond.

Group photo of the startups standing next to the London Demo Day banner

Yesterday, 20 of the most ambitious startups from London’s top universities took to the stage at London Demo Day, showcasing the incredible entrepreneurial talent emerging from UCL, LSE, King's College London, Imperial, and Queen Mary University of London: bit.ly/3UZDaus

Blocking brain damage may slow growth of brain cancer Blocking brain damage triggered by a glioblastoma, an aggressive brain cancer, may slow the growth of the cancer and allow the brain to keep working better for longer, according to a new study led by ...

Blocking brain damage triggered by a glioblastoma may slow the growth of the cancer and preserve brain function for longer, finds a new study led by Prof Simona Parrinello and Mr Ciaran Hill @uclmedsci.bsky.social @uclh.bsky.social with braintumourcharity.bsky.social‬ @cancerresearchuk.org